Perfluorooctanoic acid, usually called PFOA, is a synthetic chemical with an eight-carbon chain in which every hydrogen atom bonded to carbon has been replaced by fluorine. That fluorine coating makes it extraordinarily stable: resistant to heat, water, oil, and almost every form of natural degradation. For decades it was used in manufacturing nonstick coatings, stain-resistant fabrics, food packaging, and firefighting foam, and it is now detectable in the blood of virtually every person tested in industrialized countries. A growing body of evidence links it to elevated cholesterol, weakened vaccine responses in children, and increased risk of certain cancers, which is why regulators have begun setting drinking-water limits measured in single-digit parts per trillion.
Why PFOA Refuses to Break Down
The carbon-fluorine bond is one of the strongest in organic chemistry. In PFOA, seven carbon atoms are each surrounded by fluorine atoms, forming a rigid, helical tail that water, sunlight, soil microbes, and most industrial processes cannot crack open. That tail is attached to a carboxylic acid head group, giving the molecule a split personality: one end repels water and oil while the other dissolves readily in water. This dual nature makes PFOA an effective surfactant, able to lower the surface tension of liquids and pack tightly at the boundary between air and water.
PFOA is classified as a man-made surfactant detected in homes, offices, and throughout the natural environment, with transport occurring through both air and water. At the air-water interface it packs even more tightly than its non-fluorinated counterpart octanoic acid, a consequence of that helical fluorocarbon chain.
Very few technologies achieve complete destruction of PFOA. One that works in the laboratory is mechanochemical treatment: grinding the compound with potassium hydroxide in a ball mill can achieve near-complete breakdown of both PFOA and the related compound PFOS.
How It Spread Across the Planet
Estimated global historical emissions of perfluorocarboxylic acids, the chemical family PFOA belongs to, total roughly 3,200 to 7,300 tonnes. About 80 percent of that came from the manufacture and use of fluoropolymers, the raw materials behind nonstick and stain-resistant products.
Once released, PFOA reaches even the most remote parts of the globe by two routes. The dominant pathway is oceanic. Modeling work using coupled ocean-atmosphere circulation models estimated that ocean currents deliver roughly 15 tonnes of PFOA per year to the Arctic, with year-to-year swings driven by changes in water circulation. Field sampling confirmed this pattern: seawater collected from the Greenland Sea between 2009 and 2010 found PFOA among the most frequently detected compounds, and even the Southern Ocean near Antarctica turned up trace levels around 15 picograms per liter.
The atmospheric route is faster but smaller. Fluorotelomer alcohols, a class of industrial chemicals widely used in consumer products, break down in the atmosphere to yield PFOA and related acids. Global modeling suggests that under typical Northern Hemisphere conditions, less than 10 percent of emitted precursor converts to long-chain perfluorocarboxylic acids, translating to a possible upper bound of 2 to 50 tonnes per year of PFOA formed this way. These atmospheric episodes are brief and patchy compared with the slow, steady oceanic delivery, but they help explain why PFOA has been found in Arctic wildlife far from any factory.
How People Are Exposed
For most people, food is the primary route. Exposure estimates have attributed roughly 67 to 84 percent of median PFOA intake to food, with seafood and drinking water being stable or even rising sources in many regions despite phase-outs from consumer products. Dietary intake includes not just contaminated water but also foods grown in or near contaminated soil and seafood from affected waters.
The indoor environment is the second major route. House dust, indoor air, and contact with treated fabrics and food packaging all contribute. For most people this is a minority of their total exposure, but the range is wide. In some individuals, indoor sources have been estimated to account for up to about half of total intake, and those individuals tend to be among the highest-exposed fifth of the population overall. Dermal absorption adds a small additional fraction.
These exposures from food and drinking water remain relevant even years after major manufacturers voluntarily phased PFOA out of production, because the chemical persists in water, soil, and the food chain.
Why It Lingers in the Body
PFOA’s half-life in humans is strikingly long, but exactly how long depends on how you measure it. Clinical studies involving people with high occupational or community exposure have estimated a half-life around 116 days after exposure stops, while biomonitoring studies tracking population-level blood concentrations have produced estimates of 1.3 to 3.9 years. This discrepancy puzzled researchers for years until physiologically based modeling identified a likely explanation: saturable renal transporters.
When blood passes through the kidneys, PFOA gets filtered out like many other waste molecules. But specialized transporters on the kidney tubule cells, particularly two called OAT4 and URAT1, actively pull PFOA back into the bloodstream. This reabsorption is what makes PFOA so hard to excrete. The affinity of these transporters follows a chain-length pattern: longer perfluorinated carbon chains bind more tightly. At high blood concentrations, such as those seen in occupationally exposed workers, the transporters become saturated and some PFOA escapes into urine, which shortens the apparent half-life. At the lower concentrations typical of the general population, the transporters have plenty of capacity and reabsorb nearly everything, dragging the effective half-life out to years.
There are also pronounced differences across species and between sexes. In some laboratory animals, females clear PFOA much faster than males, differences driven largely by variation in renal clearance. In humans, the sex difference is smaller but the overall slow clearance remains a defining feature of the compound.
Effects on Cholesterol and Metabolism
The most consistently observed metabolic effect of PFOA exposure in humans is a modest increase in blood cholesterol. The C8 Science Panel, which evaluated health data from a highly exposed community near a DuPont chemical plant in West Virginia, determined in 2012 that a “probable link” existed between PFOA and high cholesterol, among other conditions.
A meta-analysis pooling data from multiple epidemiological studies quantified the association: for each interquartile-range increase in blood PFOA levels, total cholesterol rose by about 2 mg/dL, LDL cholesterol by about 1.4 mg/dL, and triglycerides by about 1.3 mg/dL. The change is real and statistically consistent across studies, though it is small on a per-person basis. For context, total cholesterol levels in a healthy adult typically run between 125 and 200 mg/dL, so a shift of 2 mg/dL is not dramatic for any single individual. At a population scale, however, even a small upward nudge in LDL cholesterol translates into a meaningful number of additional cardiovascular events.
The mechanism linking PFOA to cholesterol changes involves activation of a nuclear receptor called PPARα, which governs fatty acid metabolism in the liver. In mice engineered to carry the human version of PPARα, PFOA exposure upregulated genes involved in fatty acid oxidation and lipid storage. PFOA also disrupted the expression of liver uptake transporters through this same receptor pathway, altering how the liver handles cholesterol-carrying molecules. These effects were absent in mice lacking PPARα entirely, confirming the receptor’s central role.
Immune Effects in Children
Some of the most concerning findings around PFOA involve the immune system, particularly in young children. A landmark study in the Faroe Islands found that children with higher PFOA concentrations at age five had lower antibody levels after routine vaccinations. A doubling of PFOA exposure was associated with a 36 percent reduction in tetanus antibodies and a 25 percent reduction in diphtheria antibodies at age seven.
A separate study of 101 one-year-olds found significant negative associations between PFOA levels and antibodies against Haemophilus influenzae type b, tetanus, and diphtheria, with effect sizes ranging from a 53 to 86 percent reduction when comparing children in the lowest versus highest PFOA quintiles. These associations were specific to PFOA and were not observed for the related compound PFOS in that particular cohort.
A recent systematic review and meta-analysis of human studies on childhood PFAS exposure and immune outcomes found suggestive evidence linking PFOA and several other PFAS compounds to increased susceptibility to infections, though it characterized the evidence for antibody titer reduction as moderate to limited. The takeaway is that the signal is consistent across multiple studies and populations, but the strength of evidence varies depending on the exact immune outcome measured. Whether these reductions in vaccine antibodies translate to higher rates of actual disease in children remains an active area of research.
Cancer Risk
PFOA’s possible link to cancer has drawn intense scrutiny. The C8 Science Panel identified probable links to both kidney and testicular cancer based on the community data it reviewed. Subsequent meta-analyses have attempted to quantify the risk. One analysis estimated that each 10 ng/mL increase in serum PFOA was associated with a 16 percent increase in kidney cancer risk and a 3 percent increase in testicular cancer risk. The authors judged these associations as “most likely causal,” though they noted limitations including a small number of available studies and overlapping study populations.
The biological plausibility rests on several mechanisms. PFOA is nephrotoxic through oxidative stress and accumulates at high concentrations in renal tissue due to the same tubular reabsorption process that extends its half-life. In the liver, it disrupts lipid metabolism and has been linked to nonalcoholic fatty liver disease, which can progress toward cancer. PFOA also influences hormonal balance and immune processes, both of which play roles in cancer development and surveillance.
Reproductive and Birth Outcomes
Studies of pregnant women in a highly exposed community in West Virginia found that most reproductive outcomes, including miscarriage, preterm birth, low birth weight at term, and birth defects, showed no clear association with PFOA levels. There was a weak association with preeclampsia, with odds ratios in the range of 1.1 to 1.2 across the upper exposure groups.
Birth weight tells a somewhat different story depending on the study population. A Norwegian cohort study found that higher maternal PFOA levels were associated with babies weighing 46 to 68 grams less at birth, and children in the upper quartile of exposure were 69 to 90 grams lighter than those in the lowest quartile. These effects were stronger in girls than in boys and reached statistical significance only in girls. A reduction of 70 to 90 grams is modest for any individual pregnancy but, like the cholesterol finding, carries implications when applied across a large population, potentially shifting more births into the small-for-gestational-age category.
Drinking Water Limits and Regulatory Response
Regulatory agencies have moved toward extremely low permissible limits for PFOA in drinking water. In March 2023, the U.S. Environmental Protection Agency proposed a maximum contaminant level of 4.0 parts per trillion for PFOA and the same for PFOS. Final rules were promulgated in April 2024. To appreciate how stringent 4 parts per trillion is, it is roughly equivalent to four drops in an Olympic swimming pool. These limits reflect the compound’s potency at low concentrations, particularly its effects on cholesterol and immune function, and the fact that nearly everyone already carries some level in their blood.
The C8 Science Panel’s earlier findings helped drive these regulatory decisions. That panel, convened as part of a legal settlement involving DuPont’s Washington Works plant, examined health data from tens of thousands of community members and determined probable links between PFOA exposure and six health outcomes: high cholesterol, thyroid disease, kidney cancer, testicular cancer, pregnancy-induced hypertension, and ulcerative colitis.
The Replacement Problem
When manufacturers began phasing out PFOA around 2009, they did not stop needing its properties. The most prominent replacement is GenX (technically HFPO-DA, hexafluoropropylene oxide dimer acid), a shorter-chain fluorinated compound marketed as a safer alternative. The reality has proven more complicated.
When researchers corrected for differences in how long each chemical stays in the body, the toxicity ranking in animal studies placed GenX above PFOA, not below it. In zebrafish gut studies, HFPO-DA and a related compound, HFPO-TA, caused lower oxidative damage than PFOA but had comparable effects on inflammation and cell death. Their impact on the gut metabolome was actually greater than PFOA’s at low concentrations. The bottom line from multiple research groups is that these alternatives may not be meaningfully safer, and some could be worse on a dose-for-dose basis.
Coastal food web studies have shown that some of these newer compounds also biomagnify through the food chain. Long-chain replacement compounds showed trophic magnification factors above 1, meaning their concentrations increase as you move up the food web from invertebrates to fish. The environmental persistence of many replacement chemicals appears comparable to that of PFOA itself. Testing has confirmed that several perfluoroalkyl ether acids, including GenX, are stable under the conditions of the total oxidizable precursor assay, a laboratory method designed to break down PFAS precursors, suggesting they are as environmentally persistent as the chemicals they replaced.
PFOA in the Food You Grow
One exposure route that has received growing attention is the uptake of PFOA by food crops grown in contaminated soil. This is not a hypothetical problem: agricultural fields irrigated with contaminated water or amended with sewage sludge can contain meaningful concentrations of PFOA.
Plants absorb PFOA through their roots and transport it upward into stems and leaves. In studies of carrots, potatoes, and cucumbers grown in PFOA-contaminated soil mixed with sewage sludge, the highest transfer factors were found in vegetative parts like leaves and stems rather than in the edible roots or fruits. For cucumber leaves, the PFOA transfer factor averaged 0.88, meaning the leaves accumulated concentrations close to those in the soil. Potato peelings accumulated more PFOA than the peeled tuber underneath, and carrot peels and cores showed similar contamination levels. Lettuce, which is almost entirely leaf, accumulated PFOA at bioconcentration factors of 0.6 to 3.4 in leaves, depending on the cultivar and soil type.
Cultivar differences matter. Research on lettuce varieties grown in PFOA-polluted soil found that some cultivars accumulated far less PFOA than others. The low-accumulating varieties showed lower PFOA desorption in the root zone and stored more of what they did absorb in root cell walls rather than translocating it to edible shoots. This suggests that choosing the right plant varieties for fields near contamination sources could reduce dietary exposure, though it is no substitute for keeping PFOA out of agricultural soil in the first place.
Detecting What You Cannot See
A practical challenge in managing PFOA contamination is that standard analytical methods can measure only a fraction of the thousands of PFAS chemicals in use. Many PFAS exist as precursors, compounds that can convert into PFOA or similar stable end products through environmental or biological processes. The total oxidizable precursor assay, known as the TOP assay, was developed to address this gap. It works by chemically oxidizing unknown precursors in a sample and converting them into measurable stable PFAS like PFOA, giving a fuller picture of total contamination.
The TOP assay has its own blind spots. Testing of 15 perfluoroalkyl ether acids, including replacement chemicals like GenX, found that 10 of them were completely stable under the assay’s conditions and would not be detected as precursors because they are already terminal products. Researchers have recommended adding these ether acids to the target analyte list for the assay so that environmental samples capture a higher percentage of total PFAS contamination. The measurement challenge mirrors the broader regulatory challenge: the chemical industry keeps evolving its formulations, and detection methods need constant updating to keep pace.